Common VSG side effects include nausea, vomiting, acid reflux, and constipation due to the smaller stomach size. Nutrient deficiencies, like vitamin B12 and iron, may occur if patients don't follow their prescribed supplements. Long-term complications can include weight regain or the development of gastroesophageal reflux disease (GERD).

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

Common gastrology symptoms include stomach pain, bloating, indigestion, nausea, vomiting, and changes in bowel habits. These symptoms may indicate a range of conditions from gastritis to more serious issues like ulcers or gastrointestinal cancers.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

Slimming tablets, also known as weight-loss pills, come in various forms, including prescription medications like Orlistat and Phentermine, and over-the-counter supplements. While these pills may aid in weight loss, they should be used with caution, as they can have side effects and should be paired with healthy diet and exercise.

Sleeve banding combines two bariatric procedures: the gastric sleeve and an adjustable gastric band. It is a less common technique used to enhance the weight-loss results of the sleeve by adding additional restriction through the band. However, complications from the band have made it less favorable in recent years.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

In the UK, gastroenterology is a well-established medical field. The NHS provides access to gastroenterologists through referrals, though wait times can be significant depending on the region. Private gastroenterology services are available for those seeking faster treatment. The role of a gastroenterologist in the UK is crucial for managing digestive disorders and bariatric surgery outcomes, as well as performing diagnostic and therapeutic procedures such as endoscopies and colonoscopies.

Gastric sleeve results are typically impressive, with patients losing 50-60% of their excess body weight within the first year. The surgery also leads to improvements in obesity-related conditions like diabetes, hypertension, and sleep apnea. Long-term success depends on the patient’s ability to maintain a healthy lifestyle post-surgery.

After a stomach bypass (gastric bypass) surgery, patients must follow a strict diet to promote healing and sustain weight loss. This typically starts with liquids, then progresses to pureed and soft foods, eventually allowing small, nutrient-dense meals. Long-term dietary adjustments are crucial to prevent complications like dumping syndrome.

Slimming injections like Wegovy or Saxenda are used to assist with weight loss by controlling appetite and hunger. These injections are prescribed for individuals who struggle with obesity or weight-related health issues and have not been able to lose weight through diet and exercise alone.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

Feeling sick in your stomach can indicate nausea, indigestion, or an underlying condition such as gastritis, food intolerance, or stress. If persistent, it’s essential to consult a healthcare provider for proper diagnosis and treatment.

Gastric bypass surgery typically costs between £10,000 and £15,000 in private clinics in the UK. This surgery is a popular option for long-term weight loss and involves creating a small stomach pouch and rerouting the intestines to limit food intake and absorption.

The Allurion Balloon is not yet widely available on the NHS, though some private clinics in the UK offer it. This non-invasive procedure is an attractive option for individuals seeking a temporary weight-loss solution without the risks associated with surgery.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.